Radiogenomics can try to characterize the appearance of different lung cancers.
Lung adenocarcinomas with RET and ROS1 fusions share many radiographic features.
ROS1 tumors present as more peripheral lesions.
Genetic testing in lung adenocarcinoma can offer additional targeted treatment.